Detalhe da pesquisa
1.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
N Engl J Med
; 383(1): 35-48, 2020 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32579807
2.
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Am J Respir Crit Care Med
; 203(5): 553-564, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33252985
3.
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment.
J Allergy Clin Immunol
; 148(1): 266-271.e2, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33609624
4.
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.
J Asthma
; 58(4): 514-522, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31859541
5.
Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
Respir Res
; 21(1): 128, 2020 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-32450869
6.
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
Respir Res
; 21(1): 131, 2020 May 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32471423
7.
COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy.
COPD
; 17(5): 477-484, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32928003
8.
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
Respir Res
; 20(1): 167, 2019 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31358008
9.
Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.
Ann Allergy Asthma Immunol
; 122(5): 478-485, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30802500
10.
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.
Eur Respir J
; 52(3)2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30220648
11.
Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology.
Pulm Pharmacol Ther
; 49: 67-74, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29567116
12.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2128-2141, 2016 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27609406
13.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28061907
14.
Chronic obstructive pulmonary disease in the long-term care setting: current practices, challenges, and unmet needs.
Curr Opin Pulm Med
; 23 Suppl 1: S1-S28, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28990958
15.
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Lung
; 195(6): 739-747, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28993871
16.
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.
Respir Res
; 17(1): 73, 2016 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-27316465
17.
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
Respir Res
; 17(1): 109, 2016 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27586537
18.
Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important.
Am J Respir Crit Care Med
; 202(10): 1482, 2020 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32791005
19.
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
; 191(7): e4-e27, 2015 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25830527
20.
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
Eur Respir J
; 45(4): 879-905, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25829431